Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Handbook of Experimental Pharmacology
|
December 15, 2021
Precision Medicine and Obesity
Daniel Sacoto, Maria Daniela Hurtado, Andres Acosta
JAMA Network Open
|
September 19, 2022
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
Wissam Ghusn, Alan De la Rosa, Daniel Sacoto, et al.
Obesity Pillars
|
November 22, 2023
A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center
Alan De la Rosa, Wissam Ghusn, Daniel Sacoto, et al.
Mayo Clinic Proceedings
|
December 22, 2022
Cardiovascular Risk and Diseases in Patients With and Without Leptin-Melanocortin Pathway Variants
Lizeth Cifuentes, Alejandro Campos, Daniel Sacoto, et al.
Diabetes, Obesity & Metabolism
|
March 12, 2024
The association between previous use of anti-obesity medication and semaglutide weight loss outcomes
Wissam Ghusn, Sima Fansa, Diego Anazco, et al.
Gastro Hep Advances
|
February 6, 2023
Association Between Food Intake and Gastrointestinal Symptoms in Patients With Obesity
Wissam Ghusn, Lizeth Cifuentes, Alejandro Campos, et al.
Journal of Racial and Ethnic Health Disparities
|
May 16, 2023
The Impact of Language on Hospital Outcomes for COVID-19 Patients: A Study of Non-English Speaking Hispanic Patients
Susan Lopez, Joshua Longcoy, Elizabeth Avery, et al.
International Journal of Obesity (2005)
|
February 1, 2024
Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study
Wissam Ghusn, Sima Fansa, Diego Anazco, et al.
Obesity (Silver Spring, Md.)
|
January 21, 2026
Addition of Phentermine-Topiramate to a Digitally Enhanced Lifestyle Intervention: A Double-Blind Randomized Clinical Trial
Alejandro Campos, Wissam Ghusn, Lizeth Cifuentes, et al.
Eclinicalmedicine
|
April 3, 2023
Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept study
Lizeth Cifuentes, Wissam Ghusn, Fauzi Feris, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Handbook of Experimental Pharmacology
|
December 15, 2021
Precision Medicine and Obesity
Daniel Sacoto, Maria Daniela Hurtado, Andres Acosta
JAMA Network Open
|
September 19, 2022
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
Wissam Ghusn, Alan De la Rosa, Daniel Sacoto, et al.
Obesity Pillars
|
November 22, 2023
A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center
Alan De la Rosa, Wissam Ghusn, Daniel Sacoto, et al.
Mayo Clinic Proceedings
|
December 22, 2022
Cardiovascular Risk and Diseases in Patients With and Without Leptin-Melanocortin Pathway Variants
Lizeth Cifuentes, Alejandro Campos, Daniel Sacoto, et al.
Diabetes, Obesity & Metabolism
|
March 12, 2024
The association between previous use of anti-obesity medication and semaglutide weight loss outcomes
Wissam Ghusn, Sima Fansa, Diego Anazco, et al.
Gastro Hep Advances
|
February 6, 2023
Association Between Food Intake and Gastrointestinal Symptoms in Patients With Obesity
Wissam Ghusn, Lizeth Cifuentes, Alejandro Campos, et al.
Journal of Racial and Ethnic Health Disparities
|
May 16, 2023
The Impact of Language on Hospital Outcomes for COVID-19 Patients: A Study of Non-English Speaking Hispanic Patients
Susan Lopez, Joshua Longcoy, Elizabeth Avery, et al.
International Journal of Obesity (2005)
|
February 1, 2024
Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study
Wissam Ghusn, Sima Fansa, Diego Anazco, et al.
Obesity (Silver Spring, Md.)
|
January 21, 2026
Addition of Phentermine-Topiramate to a Digitally Enhanced Lifestyle Intervention: A Double-Blind Randomized Clinical Trial
Alejandro Campos, Wissam Ghusn, Lizeth Cifuentes, et al.
Eclinicalmedicine
|
April 3, 2023
Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept study
Lizeth Cifuentes, Wissam Ghusn, Fauzi Feris, et al.
Page
of 1